Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ZoBio logo — The Integrated Fragment Discovery Engine

ZoBio

The Integrated Fragment Discovery Engine

Founded 2004 44 employees Biotechnology, Health Care

General Information

Company Name ZoBio
Founded Year 2004
Employees 44
Industries Biotechnology, Health Care
Social

Get notified when ZoBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ZoBio

ZoBio is a biotechnology startup with the slogan "The Integrated Fragment Discovery Engine". Founded in 2004, the company offers innovative "gene to structure" research services for early stage drug discovery. ZoBio specializes in four key areas: enabling proteins for biophysical and structural biology studies, screening fragment libraries for selective ligands for pharmaceutical targets, providing 3D structural information on complexes of ligands bound to a protein, and advancing fragment "hits" through medicinal chemistry expertise. The company's proprietary technologies include Protein Domain Trapping for screening variants, TINS NMR screening technology, SPR, and high-concentration functional assays. ZoBio also offers structural information from protein NMR and crystallography, as well as medicinal chemistry focused on bridging the gap between fragment and hit. The focus on "crystallography" quality proteins and the ability to tackle structurally unprecedented and challenging proteins sets ZoBio apart in the industry. ZoBio operates within the biotechnology and healthcare industries and is currently privately held and self-funded. Although specific headquarters and latest investment details are not provided, the company's innovative approach and expertise in fragment-based drug discovery make it an intriguing prospect for potential venture capital investment.

Taxonomy: Protein production, Fragment library screening, Structural biology, Nuclear Magnetic Resonance, X-ray crystallography, Medicinal chemistry, Biophysical technologies, Drug development, Pharmaceutical target screening, High throughput protein engineering

No funding data available for ZoBio yet.

Get notified when ZoBio raises funding

ZoBio Alternatives & Competitors

ZoBio vs
SARomics Biostructures AB
SARomics Biostructures AB Sweden

Protein Crystallography & Integrated Drug Discovery: Fragment Screening & Fragment-Based Drug Design...

Series Unknown
31 employees
Biotechnology, Health Care
ZoBio vs
Domainex
Domainex United Kingdom

Enrich your medicines pipeline

Grant
100 employees
Biotechnology, Creator Economy
ZoBio vs
Nexomics Biosciences
Nexomics Biosciences United States

Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical communit...

10 employees
Biopharma, Biotechnology

FAQ About ZoBio

The Integrated Fragment Discovery Engine
ZoBio was founded in 2004.
ZoBio operates in the following industries: Biotechnology, Health Care.
ZoBio has approximately 44 employees.
Top alternatives and competitors to ZoBio include SARomics Biostructures AB, Domainex, Nexomics Biosciences, Vernalis, Shamrock Structures, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZoBio and SARomics Biostructures AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ZoBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy